Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 9.00
Ask: 9.50
Change: -0.65 (-6.74%)
Spread: 0.50 (5.556%)
Open: 9.50
High: 10.20
Low: 9.00
Prev. Close: 9.65
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

Thu, 13th May 2021 10:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

PHSC PLC, up 21% at 17.00 pence, 12-month range 7p-19.9p. Hits this 12-month high earlier on Thursday. The health & safety consulting firm expects revenue of GBP3.3 million for year to March 31, down from GBP4.4 million the year before, but underlying earnings before interest, taxes, depreciation and amortisation expected to rise to GBP520,000 from GBP255,000. Starts share buyback programme worth GBP325,000. "The company's board of directors has decided to effect the buyback programme, in part, due to the additional cash generated and held further to the successful disposal of the company's Essex property in late September 2018 for GBP305,000 gross and in light of the fact that PHSC's closing middle market share price as at May 12, being the latest practicable date prior to this announcement, of 14p represents a significant discount to its net asset value per share," it says.

----------

Goldstone Resources Ltd, up 19% at 13.80p, 12-month range 2.5p-15.49p. Says mining and ore stacking at the Homase Mine within Akrokeri-Homase gold project, Ghana, has commenced with the first mined ore having been successfully stacked onto the heap leach pad. "This is a pivotal step in the evolution of the company as we start production of the Homase Mine. Commencement of operations will lead to an ongoing revenue stream and will also establish a base for unlocking value in our AKHM project," says Chief Executive Emma Priestley.

----------

AIM - LOSERS

----------

Best of the Best PLC, down 14% at 2,665p, 12-month range 556.92p-3,570p. Says revenue and pretax profit for financial year ended April 30 to be in line with market expectations, which were raised in March. Even with Thursday's decline, shares still up 86% since start of 2021 and have grown more than four-fold over past 52 weeks.

----------

e-Therapeutics PLC, down 11% at 25.53p, 12-month range 1.01p-33p. The drug discovery company reports pretax loss of GBP4.5 million for year to January 31, widening from GBP2.9 million the year before. Widened loss largely due to administrative costs rising to GBP2.1 million from GBP1.2 million, with a management restructure in February 2020 resulting in one-off redundancy costs of GBP400,000. "Although we are not expecting the same level of one-off expenditure, we are expecting the underlying cost base to increase as the business continues to grow," company says.

----------

Online Blockchain PLC, down 10% at 41.43p, 12-month range 11p-127.5p. The blockchain research and development company falls after Tesla hit the brakes on letting people pay for electric cars with bitcoin, saying the computing-intense mining process of creating new cryptocurrency spews climate-harming emissions. "We are concerned about rapidly increasing use of fossil fuels for bitcoin mining and transactions, especially coal, which has the worst emissions of any fuel," Tesla Chief Executive Elon Musk says in a tweet. "Cryptocurrency is a good idea on many levels and we believe it has a promising future, but this can not come at great cost to the environment." The cryptocurrency initially tumbled after Musk's tweet, before recovering slightly to around USD50,773 early Thursday, according to cryptocurrency news outlet Coindesk. Main Market-listed cryptocurrency mining firm Argo Blockchain falls 11%.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Oct 2019 18:49

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Invesco's Holding In e-Therapeutics Drops To Zero From 32%

Read more
7 Oct 2019 09:14

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, Collaboration Income

Read more
7 Oct 2019 09:13

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

e-therapeutics Loss Narrows On Lower Costs, New Collaboration Income

Read more
13 Aug 2019 12:16

e-Therapeutics Partners With Pharma Firm For Drug Discovery

(Alliance News) - e-Therapeutics PLC on Tuesday said it has agreed to work with an undisclosed global pharmaceutical company, on a project in a specific area of biology, associated with occurs is

Read more
10 Jun 2019 13:33

Woodford Raises GBP500 Million From Flurry Of London Share Sales (ALLISS)

LONDON (Alliance News) - Over the past week, fund manager Neil Woodford's Woodford Investment Management has conducted a fire sale of its stakes in 20 London-listed companies - raising in of -

Read more
5 Mar 2019 11:50

e-Therapeutics Annual Loss Narrows Amid Reduced Research Costs

LONDON (Alliance News) - e-Therapeutics PLC on Tuesday said its annual loss narrowed as research and development costs were significantly cut.For the year ended January, the drug discovery

Read more
26 Feb 2019 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 27 February ITVFull Year ResultsRio TintoFull Year Results (at 0600 James's

Read more
10 Dec 2018 14:30

E-Therapeutics launches research collaboration with Novo Nordisk

(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more
4 Oct 2018 11:08

e-Therapeutics narrows interim losses as it eyes commercial viability

(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.

Read more
4 Oct 2018 10:31

e-Therapeutics Interim Loss Narrows As It "Carefully" Manages Costs

LONDON (Alliance News) - e-Therapeutics PLC said Thursday that its half-year loss narrowed as it continued to effectively and "carefully" manage its costs.For the six months ended

Read more
27 Sep 2018 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 28 September United UtilitiesTrading Statement Baillie Gifford Shin Year 1 events 2 3

Read more
24 May 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Friday 25 MayHochschild MiningFerrexpoKeywords Mutual (re managed 28 events 29 Stobart Life (re of

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.